| Having trouble reading this newsletter? Click here to see it in your browser. You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe. |
 9 February 2010  |
 |
|
Dealmakers Update February 2010Sponsored this month by: PharmaPartnering Live 2010 May 26-27, 2010 The Virtual Partnering Event for the Pharmaceutical Industry. This will be a first of its kind virtual event for licensing and business development teams to include academic tech transfer as well as global licensing and technology alliance divisions at major pharmaceutical companies, covering both the Brand and Generic Pharmaceutical Industry markets Register online at http://www.pharmapartneringlive2010.com/.
Editor's cornerPartnering activity has been progressing at a pace since the start of the year. You can track these latest deals using our In the news and Scorecard tools. Now is the time to start planning your partnering event attendance for 2010 - the following are our suggested must attend events: BioWindhover/PSO, BioEurope Spring, BioNetwork East . In addition, the new and innovative PharmaPartneringLive 2010 seeks to provide the first completely virtual partnering event in May 2010. NEW FOR 2010 Due to popular demand, we have added a new interim newsletter - Dealmakers Round-Up. This new newsletter is delivered to all our recipients towards the end of each month, providing up to the minute access to our industry round-up and in the news sections cthat ontinue to provide insight and are updated daily online, providing you with the latest trends from the world's most respected publishers and deal news direct from biopharma companies as they are announced. You can also follow these updates via our LinkedIn and Twitter pages - sign up here. Just published: Partnering Agreements with ..... Abbott, Actavis, Alcon, Allergan, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Cephalon, Chugai, CSL, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, Forest, Genentech, Genzyme, Gilead, GlaxoSmithKline, Hospira, Johnson & Johnson, Lundbeck, Menarini, Merck & Co, Merck Serono, Mitsubishi Tanabe, Mylan, Novartis, Novo Nordisk, Nycomed, Otsuka, Prizer, Ratiopharm, Roche, Sanofi-Aventis, Servier, Shire, Solvay, Takeda, Teva, UCB, Watson..... Full details can be viewed for each report here. Our publishing arm has been busy introducing new reports - here are just a few of the titles to facilitate partnering in 2010:
All for now! -- Steve Poile -- In the newsThe following are just some of the deals involving bigpharma announced in the last few weeks: Deals of note so far in February 2010:
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature. Signup for our updates via LinkedIn and Twitter. Partnering roundupJust some of the articles picked up by Roundup during early February:
Signup for our updates via LinkedIn and Twitter. Scorecard updateUpdated today - February 9, 2010 Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index. Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month. In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard. Latest update! Bigpharma partnering activity 2006 to present - view details here Best practice articlesBest Partnering Practices - Just Common Sense, Part 1 We, on the side of the organisers, have always been in the position of an observer. We see what is going on during the week-long run-up to a euroPLX Meeting, and during the two days of the event itself - more Drug Repurposing and Repatenting Better scientific understanding of drug interactions with enzymes at the molecular level has allowed some old, ‘failed’ molecules to be used for novel purposes - more
Medtech Companies Bank on EuroMedtech for Financing and Partnerships In only its second year, EBD Group’s partnering event for the medical technology industry, EuroMedtech, has become the premier destination for emerging innovator companies and start-ups to seek out and secure funding - more Royalty Rates For Technology Transactions An interesting study was carried out between 1990 and 2007 which discovered that the most frequently negotiated royalty rate is 5% of net sales - more
Read all our partnering best practice articles. New and updated reportsNew report titles: CurrentPartnering has published new titles: Drug Delivery Partnering Agreements in Pharma, Biotech and Diagnostics Provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading companies
Partnering Agreements in Diagnostics Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies
Option & Evaluation Agreements in Pharma and Biotech The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies Royalty Financing Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Revised and updated reports: CurrentPartnering has revised and updated its most popular reports: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity New from Datamonitor: Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines Forthcoming eventsHere are some of our suggested events for spring 2010: BIO-Windhover 2010/Pharmaceutical Strategic Outlook 2010 New York, USA - February 23-25, 2010 - more details BioEurope Spring 2010 Barcelona, Spain - March 8-10, 2010 - more details Collaborations, Deals and Alliances Philadelphia, PA, USA - April 11-14, 2010 - more details MedTech Investing Europe 2010 Paris, France - April 29-30, 2010 - more details BIO International Convention 2010 Chicago, IL, USA - May 3-6, 2010 - more details Annual C21 Bioventures 2010 Napa, CA, USA - May 25-27, 2010 - more details PharmaPartnering Live 2010 Online powered by ON24 - May 26-27, 2010 - more details EuroMedtech 2010 Leipzig, Germany - June 1-2, 2010 - more details EuroPLX 43 Berlin Berlin, Germany - June 14-15, 2010 - more details People on the moveThe following people have been reported on the move during February 2010: Robert Phelps,Michael Markels, David Poorvin, Patrick Gallagher, Nigel Clark to name just a few read more about the latest people on the move If you have news about a business development executive who is on the move - let us know Partnering resourcesCurrent Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries. The following topic areas are available - updated regularly:
Missing something? Let us know and we will include all appropriate resources.
Contact usSteve Poile, Editor Web: http://www.CurrentPartnering.com Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom Tel: +44 7896 656732 Fax: +44 8703 305993
Advertizing and sponsorshipCurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online. or contact us to discuss your requirements.
About CurrentPartneringCurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
|
|
|
|
Sponsored by: 
CurrentPartnering reports
|
|
|
||
|
 |
|